Director/PDMR Shareholding (6414Z)

TIDMHIK

RNS Number : 6414Z

Hikma Pharmaceuticals Plc

19 March 2012

Hikma Pharmaceuticals PLC - Share Transactions

LONDON, 19 March 2012: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have exercised awards which vested on 19 March 2012 under the 2005 Long Term Incentive Plan ("LTIP") and which the holders were required to exercise as part of the vesting process. The exercise price under the LTIP is GBPnil. The persons concerned elected to retain all the shares exercised.

In accordance with DTR 3.1.2R and s.793 of the Companies Act 2006, Hikma announces that the following transactions took place in London over the Company's Ordinary Shares of 10p each as detailed below.

 
 PDMR              Type of Transaction    Exercised        Date         Price     Shares      Remaining 
                                                                                   Disposed    Holding 
----------------  ---------------------  ---------------  -----------  --------  ----------  ------------------ 
                   Exercise               115,000 (0.06%   19 March 
 Said Darwazah      of LTIP 2009           ISC)             2012        GBP7.27   Nil         418,445 (0.21%) 
----------------  ---------------------  ---------------  -----------  --------  ----------  ------------------ 
                   Exercise                                19 March 
 Mazen Darwazah     of LTIP 2009          69,000            2012        GBP7.27   Nil         868,225 (0.44%) 
                                           (0.04% ISC) 
 --------------------------------------  ---------------  -----------  --------  ----------  ------------------ 
 Khalid            Exercise                                19 March 
  Nabilsi           of LTIP 2009          46,000            2012        GBP7.27   Nil         196,784 (0.10%) 
                                           (0.02% ISC) 
 --------------------------------------  ---------------  -----------  --------  ----------  ------------------ 
                   Exercise               27,600 (0.01%    19 March 
 Riad Mishlawi      of LTIP 2009           ISC)             2012        GBP7.27   Nil         42,600 
                                                                                               (0.02%) 
 --------------------------------------  ---------------  -----------  --------  ----------  ------------------

- ENDS -

Enquiries

Henry Knowles +44 20 7399 2760

Company Secretary, Hikma Pharmaceuticals PLC

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non--branded generic and in--licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2011, Hikma achieved revenue of $918.0 million and profit attributable to shareholders of $80.1 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBLGDXCSBBGDC

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024